Methods and compositions of derivatives of probucol for the treatment of diabetes

作者: Robert A. D. Scott

DOI:

关键词:

摘要: This present invention provides methods and pharmaceutical compositions for the treatment or prophylaxis of diabetes related disorders, comprising administration an effective amount a monoester probucol, particularly monosuccinic acid ester, pharmaceutically acceptable salt derivative thereof.

参考文章(47)
Merck Sharp and Dohme Research Laboratories (Rahway, N.J.), The Merck Manual of Diagnosis and Therapy ,(1982)
Kim S. Chen, Roger A. Parker, Steven J. Busch, James E. Matt, Mark T. Yates, Mark J. Vaal, Michael J. Edwards, Paul S. Wright, Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents ,(1997)
Jayraz Luchoomun, James Sikorski, Uday Saxena, Cynthia Sundell, Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters ,(2002)
Cynthia L. Sundell, Charles Kunsch, Compounds and methods for treating diabetic vascular diseases ,(2005)
Simon J. T. Mao, Roger A. Parker, 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents ,(1990)
Jean-Paul Vilaine, Claude Guillonneau, Gilbert Regnier, Albert Lenaers, Christine Breugnot, Substituted phenoxyisobutyric acids and esters ,(1994)